Silent myocardial ischemia is a major component of the total ischemic burden for patients with coronary artery disease (CAD); it is estimated that between 2 and 3 million persons with stable CAD have evidence of silent ischemia. Although statistically hard data are lacking on how treatment affects prognosis, management should aim to reduce or eliminate myocardial ischemia by risk factor modification, aggressive medical therapy and, if appropriate, myocardial revascularization.
|Original language||English (US)|
|Publication status||Published - Feb 1 2009|
ASJC Scopus subject areas